Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-31 @ 2:14 PM
Study NCT ID:
NCT01973660
Status:
COMPLETED
Last Update Posted:
2018-09-19
First Post:
2013-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
Sponsor:
SOLTI Breast Cancer Research Group
Organization: